Background: This study aims to investigate the safety and efficacy of guideline-directed fluid resuscitation (GDFR) compared with conservative fluid management in end-stage renal disease (ESRD) patients with sepsis by evaluating 90-day mortality and intubation rate. Methods: Following PRISMA guidelines, a systematic review was conducted across multiple databases using specific keywords and controlled vocabulary. The search strategy, implemented until October 1, 2023, aimed to identify studies examining fluid resuscitation in ESRD patients with sepsis. The review process was streamlined using Covidence software. A fourth reviewer resolved discrepancies in study inclusion. A random-effects model with the generic Mantel–Haenszel method was preferred for integrating odds ratios (ORs). Sensitivity analysis and publication bias analysis were performed. Results: Of the 1274 identified studies, 10 were selected for inclusion, examining 1184 patients, 593 of whom received GDFR. Four studies were selected to investigate the intubation rate, including 304 patients. No significant mortality or intubation rate difference was spotted between both groups [OR = 1.23; confidence interval (CI) = 0.92-1.65; I2 = 0% and OR = 1.91; CI = 0.91-4.04]. In most studies, sensitivity analysis using the leave-one-out approach revealed higher mortality and intubation rates. The Egger test results indicated no statistically significant publication bias across the included studies. Conclusion: Our research contradicts the common assumption about the effectiveness of GDFR for sepsis patients with ESRD. It suggests that this approach, while not superior to the conservative strategy, may potentially be harmful.
van der PollTvan de VeerdonkFLSciclunaBPNeteaMG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol.2017;17(7):407‐420.
2.
GottsJEMatthayMA. Sepsis: pathophysiology and clinical management. Br Med J.2016;353(i1585):26–40.
3.
EvansLRhodesAAlhazzaniW, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063‐e1143.
4.
JonesTWSmithSEVan TuylJSNewsomeAS. Sepsis with preexisting heart failure: management of confounding clinical features. J Intensive Care Med. 2021;36(9):989‐1012.
5.
BoccioEHaimovichADJacobVMaciejewskiKRWiraCRBelskyJ. Sepsis fluid metric compliance and its impact on outcomes of patients with congestive heart failure, end-stage renal disease or obesity. J Emerg Med. 2021;61(5):466‐480.
6.
TrivediVBavishiCJeanR. Impact of obesity on sepsis mortality: a systematic review. J Crit Care. 2015;30(3):518‐524.
7.
KoomanJPvan der SandeFM. Body fluids in end-stage renal disease: statics and dynamics. Blood Purif. 2019;47(1-3):223‐229.
8.
Abou DagherGHarmoucheEJabbourEBachirRZebianDBou CheblR. Sepsis in hemodialysis patients. BMC Emerg Med.2015;15(15):1‐6.
9.
SarnakMJJaberBL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758‐1764.
10.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539‐1558.
11.
EggerMSmithGDSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. Br Med J.1997;315(7109):629‐634.
12.
HozoSPDjulbegovicBHozoI. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol.2005;5(5):1‐10.
13.
RiceDMRatliffPDJuddWRKseibiSAEberweinKA. Assessing the impact of CKD on outcomes in septic shock patients receiving standard vs reduced initial fluid volume. Am J Emerg Med. 2020;38(10):2147‐2150.
14.
KuttabHILykinsJDHughesMD, et al.Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med. 2019;47(11):1582.
15.
LeeJJTaylorSLAdamsJY. Fluid resuscitation and mortality in sepsis with end-stage renal disease. C23. Critical care: what can be measured can be improved-investigating the epidemiology and outcomes of patients with acute critical illness: American Thoracic Society; 2017. p. A5020.
16.
RajdevKLeiferLSandhuG, et al.Fluid resuscitation in patients with end-stage renal disease on hemodialysis presenting with severe sepsis or septic shock: a case control study. J Crit Care. 2020;55(1):157‐162.
17.
RajdevKLeiferLSandhuG, et al.Aggressive versus conservative fluid resuscitation in septic hemodialysis patients. Am J Emerg Med. 2021;46(3):416‐419.
18.
RosenDWhelanKHaoS, et al.Excess fluid resuscitation of septic patients with congestive heart failure or end stage renal disease may be associated with increased mortality. TP53. TP053 sepsis and multiorgan failure: American Thoracic Society; 2021. p. A2714.
19.
HuebingerRMWaliaSYealyDMKellumJAHuangDTWangHE. Outcomes of end-stage renal disease patients in the PROCESS trial. J Am College Emerg Phys Open. 2021;2(1):e12358.
20.
National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499‐510.
21.
ChernobyKDzingleAElefritzJ, et al.7: Impact of fluid resuscitation in end-stage renal disease patients with septic shock. Crit Care Med. 2022;50(1):4.
22.
GoveroABYarrarapuSNSHarrisonMF, et al.Surviving sepsis guideline-directed fluid resuscitation: an assessment of practice patterns and impact on patient outcomes. Critical Care Explorations. 2022;4(7):25-49.
23.
KhanRAKhanNABauerSR, et al.Association between volume of fluid resuscitation and intubation in high-risk patients with sepsis, heart failure, end-stage renal disease, and cirrhosis. Chest. 2020;157(2):286‐292.
24.
LiuVXMorehouseJWMarelichGP, et al.Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values. Am J Respir Crit Care Med.2016;193(11):1264‐1270.
25.
EgiMOguraHYatabeT, et al.The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care.2021;9(1):1‐144.
26.
NguyenHBRiversEPAbrahamianFM, et al.Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):54.e1.
27.
LevyMMEvansLERhodesA. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018;44(1):925‐928.
28.
DellingerRPLevyMMRhodesA, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165‐228.
29.
DellingerRPCarletJMMasurH, et al.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858‐873.
30.
LoweKMHeffnerACKarvetskiCH. Clinical factors and outcomes of dialysis-dependent end-stage renal disease patients with emergency department septic shock. J Emerg Med. 2018;54(1):16‐24.
31.
GordonDSpiegelR. Fluid resuscitation: history, physiology, and modern fluid resuscitation strategies. Emerg Med Clin. 2020;38(4):783‐793.
32.
ByrneLVan HarenF. Fluid resuscitation in human sepsis: time to rewrite history?Ann Intensive Care.2017;7(2):1‐8.
33.
WentowskiCMewadaNNielsenND. Sepsis in 2018: a review. Anaesth Intensive Care Med. 2019;20(1):6‐13.
34.
KarbianNAbutbulAEl-AmoreR, et al.Apoptotic cell therapy for cytokine storm associated with acute severe sepsis. Cell Death Dis.2020;11(7):535.
35.
MarikPBellomoR. A rational approach to fluid therapy in sepsis. Br J Anaesth.2016;116(3):339‐349.
36.
JacobiJ. The pathophysiology of sepsis—2021 update: part 1, immunology and coagulopathy leading to endothelial injury. Am J Health-Syst Pharm.2022;79(5):329‐337.
37.
AndrewsBMuchemwaLKellyPLakhiSHeimburgerDCBernardGR. Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med. 2014;42(11):2315‐2324.
38.
AndrewsBSemlerMWMuchemwaL, et al.Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA. 2017;318(13):1233‐1240.
39.
BrownRMSemlerMW. Fluid management in sepsis. J Intensive Care Med. 2019;34(5):364‐373.
40.
WalliaRGreenbergAPirainoBMitroRPuschettJB. Serum electrolyte patterns in end-stage renal disease. Am J Kidney Dis.1986;8(2):98‐104.
41.
VincentJLDe BackerDWiedermannCJ. Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care. 2016;35(1):161‐167.
42.
Fernández-SarmientoJLampreaSBarreraS, et al.The association between prolonged capillary refill time and microcirculation changes in children with sepsis. BMC Pediatr.2024;24(1):68.
43.
Fernández-SarmientoJSalazar-PeláezLMAcevedoL, et al.Endothelial and glycocalyx biomarkers in children with sepsis after one bolus of unbalanced or balanced crystalloids. Pediatr Crit Care Med.2023;24(3):213‐221.
44.
BeranAAltorokNSrourO, et al.Balanced crystalloids versus normal saline in adults with sepsis: a comprehensive systematic review and meta-analysis. J Clin Med.2022;11(7):1971.
45.
ChangRHolcombJB. Choice of fluid therapy in the initial management of sepsis, severe sepsis, and septic shock. Shock. 2016;46(1):17‐26.
46.
NeyraJACanepa-EscaroFLiX, et al.Association of hyperchloremia with hospital mortality in critically ill septic patients. Crit Care Med. 2015;43(9):1938‐1944.
47.
JonesAEShapiroNITrzeciakS, et al.Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739‐746.
48.
PopeJVJonesAEGaieskiDF, et al.Multicenter study of central venous oxygen saturation (ScvO2) as a predictor of mortality in patients with sepsis. Ann Emerg Med. 2010;55(1):40‐46.e1.
49.
BoydJHForbesJNakadaTWalleyKRRussellJA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259‐265.
50.
ChaudhuriDHerrittBLewisK, et al.Dosing fluids in early septic shock. Chest. 2021;159(4):1493‐1502.
51.
Prism Investigators. Early, goal-directed therapy for septic shock—a patient-level meta-analysis. N Engl J Med. 2017;376(23):2223‐2234.
52.
ChenHZhuZZhaoC, et al.Central venous pressure measurement is associated with improved outcomes in septic patients: an analysis of the MIMIC-III database. Crit Care.2020;24(3):1‐10.
53.
MitchellOJTeranFPatelSBastonC. Critical care echocardiography: a primer for the nephrologist. Adv Chronic Kidney Dis.2021;28(3):244‐251.
54.
CortellaroFFerrariLMolteniF, et al.Accuracy of point of care ultrasound to identify the source of infection in septic patients: a prospective study. Intern Emerg Med.2017;12(1):371‐378.
55.
Integrated multiorgan bedside ultrasound for the diagnosis and management of sepsis and septic shock. Seminars in respiratory and critical care medicine: Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY, 2021.
56.
YuDTPlattRLankenPN, et al.Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med. 2003;31(12):2734‐2741.
57.
GanterMTAlhashemiJAAl-ShabasyAM, et al.Continuous cardiac output measurement by un-calibrated pulse wave analysis and pulmonary artery catheter in patients with septic shock. J Clin Monit Comput. 2016;30(2):13‐22.
58.
CruzKFranklinC. The pulmonary artery catheter: uses and controversies. Crit Care Clin. 2001;17(2):271‐291.
59.
YoussefNWhitlockRP. The routine use of the pulmonary artery catheter should be abandoned. Can J Cardiol. 2017;33(1):135‐141.
60.
FilipskaABohdanBWieczorekPPHudzN. Chronic kidney disease and dialysis therapy: incidence and prevalence in the world. Pharmacia. 2021;68(2):463‐470.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
